Nieuws
AGILeBiotics winner Progress Investors Forum Prize
During the Investors Forum fourteen young companies had the opportunity to present their company to interesting partners and discuss their business strategy, technology direction and capital-raising plan. On stage of the 15th edition of the Dutch Life Sciences Conference, AGILeBiotics became the proud winner of the Progress Investors Forum Prize. The Venture Challenge alumnus was awarded a partnering ticket, national or international, with a total value of €2,500.
Invest-NL a fact
De Eerste Kamer heeft ingestemd met een wetsvoorstel voor de oprichting van Invest-NL. Met de oprichting van Invest-NL stimuleert het kabinet investeringen die nu al kunnen plaatsvinden bij ondernemingen die gericht zijn op de grote transitie-opgaven en de doorgroei van ondernemingen. In totaal krijgt Invest-NL 2,5 miljard euro te besteden, waarvan 800 miljoen euro wordt ondergebracht bij ontwikkelingsbank FMO.
Opening of the Dutch TechMed centre, a hotspot for healthcare innovation
On 29 November, King Willem-Alexander opened the University of Twente’s brand-new TechMed Centre. The center will be a meeting point for students, scientists, doctors, patients and entrepreneurs, and it will be a place where new ideas for personalized and less invasive health care see the light.
Register now as a healthcare provider for the Health Valley Bridge prize 2020
Health Valley nodigt zorgaanbieders die actief zijn in cure en/of care, uit om vóór 1 februari 2020 projecten in te dienen waarin ze samen met bedrijven werken aan zorginnovaties die op patiënten gericht zijn. Dit jaar is gekozen voor de thema's Robotica en Blockchain. Het meest veelbelovende project ontvangt de prestigieuze prijs en het bedrag van € 15.000 euro dat eraan verbonden is.
Oncode Institute invests 4 million euros in new technology for cancer research in the Netherlands
Oncode Institute invests 4 million euros in unique, state-of-the-art technology for cancer research. Five projects in the field of Single Cell protein measurements and DNA sequencing, Artificial Intelligence and Deep Learning amongst others, have been awarded within the Infrastructure & Technologies Programme.
The winner of the Venture Challenge Fall 2019 is BIMINI Biotech
In front of an audience of companies and organisations whose mission is to help realise the further development and growth of the Dutch life sciences industry, the winner of the Venture Challenge was announced. On the stage of the Dutch Life Sciences Conference, BIMINI Biotech became the proud winner of this year’s fall edition. The innovative spin-off from the University Medical Center Utrecht aims to target the growth hormone receptor for the treatment of cancer.
MSD doubles biotech manufacturing in Oss
MSD, het grootste geneesmiddelenbedrijf in Nederland, verdubbelt de komende jaren haar capaciteit voor biotechproductie in Oss. Met de vergroting van de capaciteit en de nieuwe faciliteiten kan MSD vanuit Oss geneesmiddelen leveren aan de rest van de wereld.
Innovative research into the healing of hearts
Met steun van de Hartstichting is een groot hartonderzoek gestart. Het doel is om harten volledig en blijvend te genezen. Wetenschappers onderzoeken hoe ze een hart kunnen herstellen buiten het lichaam van de patiënt.
The first edition of the Health Impact Accelerator is a fact
Last month, the first edition of the Health Impact Accelerator (HIA) started. In just ten weeks, the participants are prepared to become social entrepreneurs. During the HIA they are introduced to the added value - and the challenges - of social entrepreneurship. Moreover, they translate their idea into a solid business case.
Health~Holland Newsflash November 2019
The Health~Holland Newsflash of November 2019 is out now. Read our newsletter that brings you the latest developments in the Top Sector Life Sciences & Health and get insight in the remarkable progress that is taking place in the Dutch Life Sciences & Health sector.